The search to discover why 'outliers' survive deadliest cancers
When Herve found out he had glioblastoma—the most aggressive form of brain cancer—at the age of 40, he made a deal with himself.
Mar 20, 2024
0
0
When Herve found out he had glioblastoma—the most aggressive form of brain cancer—at the age of 40, he made a deal with himself.
Mar 20, 2024
0
0
Over the past decade, regulatory agencies such as the Federal Drug Administration (FDA) in the United States and the and the European Medicines Agency (EMA) in the European Union have put programs in place to get new drugs ...
Mar 13, 2024
0
0
More than one billion people around the world are now suffering from obesity with the number having more than quadrupled since 1990, according to a study released by The Lancet medical journal.
Mar 3, 2024
0
1
Canada on Thursday unveiled a framework for a universal drug plan that, once fully implemented, would mark the biggest expansion of its publicly funded health care system in decades.
Mar 1, 2024
0
0
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, according to researchers ...
Feb 27, 2024
0
3
Weizmann Institute scientists have discovered two small molecules that can cross the blood-brain barrier in mice, slowing and even reversing the effects of Huntington's, which is incurable.
Feb 26, 2024
0
40
More than 40% of Americans know someone who has died of a drug overdose and about one-third of those individuals say their lives were disrupted by the death, according to a new RAND study.
Feb 21, 2024
0
0
A team of medical researchers with affiliations to British multinational pharmaceutical and biotechnology company GlaxoSmithKline (GSK) has found that a new antibiotic drug the company developed to treat urinary tract infections ...
A new research perspective titled "Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma" has been published in Oncotarget.
Feb 7, 2024
0
1
Generative artificial intelligence platforms, from ChatGPT to Midjourney, grabbed headlines in 2023. But GenAI can do more than create collaged images and help write emails—it can also design new drugs to treat disease.
Feb 7, 2024
0
174